Edwin M. Posadas - Concepedia

Author

Edwin M. Posadas

Also Known As

E M Posadas, E Posadas, E. M. Posadas, E. Posadas, E.M. Posadas, Edwin M POSADAS, Edwin M Posadas, Edwin M. Posadas, Edwin Melencio Posadas, Edwin Posadas

419

Publications

8.7K

Citations

H-Index

Concepts

All Affiliations

Cedars-Sinai Medical Center University of California, Los Angeles California NanoSystems Institute University of Chicago University of Michigan

About

Edwin M. Posadas is an author at Cedars-Sinai Medical Center specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	35	2K
2	Engineering	6	6	351
3	Biomedical Engineering	4	4	249
4	Health Sciences	1	1	10
5	Biomolecular Engineering	1	1	42

Edwin M. Posadas

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma Tatyana Vagner, Cristiana Spinelli, Valentina R. Minciacchi, Journal of Extracellular Vesicles	2018	369
Combination Targeted Therapy With Sorafenib and Bevacizumab Results in Enhanced Toxicity and Antitumor Activity Nilofer S. Azad, Edwin M. Posadas, Virginia E. Kwitkowski, Journal of Clinical Oncology	2008	336
Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy Shuang G. Zhao, S. Laura Chang, Nicholas Erho, JAMA Oncology	2017	296
Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer Karen A. Autio, Robert Dreicer, Justine Anderson, JAMA Oncology	2018	241
Large oncosomes mediate intercellular transfer of functional microRNA Matteo Morello, Valentina R. Minciacchi, Paola de Candia, Cell Cycle Functional GenomicsMirna AbundantOncogenic AgentPathologyExtracellular Microvesicles	2013	229
Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring Na Sun, Yi‐Te Lee, Ryan Y. Zhang, Nature Communications	2020	222
Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer Evan Y. Yu, George Wilding, Edwin M. Posadas, Clinical Cancer Research	2009	218
Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis Sajni Josson, Murali Gururajan, Shian‐Ying Sung, Oncogene Developmental BiologyMedicineEpithelial-mesenchymal InteractionsProstatic DiseaseMicrorna Detection	2014	205
A Phase II Clinical Trial of Sorafenib in Androgen-Independent Prostate Cancer William L. Dahut, Charity D. Scripture, Edwin M. Posadas, Clinical Cancer Research	2008	178
Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming Rajeev Mishra, Subhash Haldar, Veronica R. Placencio, Journal of Clinical Investigation Epigenetic ChangeCancer BiologyEpigeneticsTumor BiologyBlood Glutamine Levels	2018	155

Page 1